Building collaborative partnerships.
Promoting cardiac health equity.
OUR MISSION
We are Changing the Cardiac Patient Monitoring Ecosystem.
Lohman Technologies is the creator of the HomECG+ solution, an FDA-cleared, clinical grade remote monitoring solution for atrial fibrillation (Afib) detection. Lohman Technologies' mission is to continuously improve and impact the care continuum through innovative remote cardiac monitoring, collaborative partnerships, and the promotion of health equity. The HomECG+ patented mobile solution connects patient data directly with their healthcare providers without the need for a smartphone or WIFI technology. For more information about how Lohman Technologies is connecting patients, providers and peace-of-mind, visit www.homecg.com.
Our Journey So Far
Missy R., FNP
This type of data is a powerful decision-making tool.
Hugh C., M.D., F.A.C.C., FHRS, FAHA
It is the right kind of solution for patients, because AFib is a lifetime condition. I’m very impressed by the device.
John N., MD
The quality of the ECGs it captures is excellent.
Paul, MD
The HomECG+ has been able to identify AFib on multiple patients when all other methods have failed.